Bio-Techne has opened a 10,000-square-foot facility in Bristol dedicated to producing GMP-grade small molecules for the cell therapy market. The site features seven cleanrooms designed to help developers scale their manufacturing processes, supporting the transition of new therapies from early development to commercial use.

About the AI positivity score